Is Parsonage-Turner Syndrome hereditary?

Parsonage-Turner Syndrome, also known as neuralgic amyotrophy, is generally considered an acquired, immune-mediated condition rather than a strictly hereditary disease. While rare familial cases have been documented, most individuals diagnosed with Parsonage-Turner Syndrome do not have a genetic predisposition, and there is no standard inheritance pattern associated with the vast majority of cases.

Is Parsonage-Turner Syndrome hereditary?

In the vast majority of clinical presentations, Parsonage-Turner Syndrome is not hereditary. It is classified as an inflammatory neuropathy, typically triggered by immune system activation, such as a recent viral infection, surgery, or vaccination. Because the condition is not caused by a single inherited gene mutation in most patients, it does not follow Mendelian inheritance patterns like autosomal dominant or recessive inheritance. While the condition can be life-altering, it is rarely passed from parent to child through the germline.

Are there familial forms of Parsonage-Turner Syndrome?

Although Parsonage-Turner Syndrome is usually sporadic, there is a recognized, rare form known as Hereditary Neuralgic Amyotrophy (HNA). In these specific familial cases, the condition is inherited in an autosomal dominant pattern. Research has identified that mutations in the SEPT9 gene are responsible for many of these hereditary instances. Unlike the sporadic form of Parsonage-Turner Syndrome, individuals with HNA may experience recurrent episodes of brachial plexus neuritis throughout their lives, often triggered by minor stressors.

Is genetic testing recommended for patients?

Genetic testing is not routinely recommended for the average patient with Parsonage-Turner Syndrome because the condition is typically acquired. However, genetic evaluation may be considered in specific scenarios:

• If there is a strong family history of recurrent brachial plexus neuritis.


• If the onset occurs in early childhood with no identifiable external trigger.


• If the patient wishes to differentiate between the sporadic, one-time form of Parsonage-Turner Syndrome and the rare familial HNA variant.


• If a physician suspects a genetic predisposition after observing multiple affected relatives across generations.

What is the role of genetic counseling?

For the 160 members of the DiseaseMaps community and others navigating this diagnosis, genetic counseling provides clarity regarding risk. If a patient is diagnosed with the rare familial form linked to the SEPT9 mutation, a genetic counselor can explain that there is a 50% chance of passing the mutation to each offspring. Conversely, for those with sporadic Parsonage-Turner Syndrome, the risk to children is considered to be the same as the general population, as there is no evidence of a hereditary component in these cases. Counseling helps families distinguish between the anxiety of a recurring condition and the reality of a one-time, immune-mediated event.

Are de novo mutations common in this condition?

De novo (spontaneous) mutations are not considered a primary driver of sporadic Parsonage-Turner Syndrome. Because the syndrome is primarily driven by inflammatory and autoimmune mechanisms, medical researchers focus on environmental triggers rather than genetic mutations. In the rare cases of Hereditary Neuralgic Amyotrophy, de novo mutations in the SEPT9 gene can occur, but these are statistically uncommon compared to inherited cases within the few families known to carry the gene.

Next steps

• Consult with a neurologist or neuromuscular specialist to confirm your diagnosis and rule out atypical presentations.


• If you have a strong family history of recurrent nerve pain and weakness, ask your physician for a referral to a clinical geneticist.


• Join the 160 members of the DiseaseMaps.org community to share experiences and track symptoms with others who understand the journey of Parsonage-Turner Syndrome.


• Maintain a detailed symptom diary to help your clinical team identify potential triggers for future episodes.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Neuralgic Amyotrophy.


• Orphanet: Hereditary neuralgic amyotrophy.


• OMIM (Online Mendelian Inheritance in Man): Neuralgic Amyotrophy; NNA.


• PubMed: Clinical and genetic updates on Parsonage-Turner Syndrome and SEPT9-related disorders.